NL110232C - - Google Patents

Info

Publication number
NL110232C
NL110232C NL110232DA NL110232C NL 110232 C NL110232 C NL 110232C NL 110232D A NL110232D A NL 110232DA NL 110232 C NL110232 C NL 110232C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL110232C publication Critical patent/NL110232C/xx
Priority claimed from CH6704658A external-priority patent/CH370082A/de
Priority claimed from CH6704958A external-priority patent/CH371799A/de
Priority claimed from CH6820159A external-priority patent/CH371800A/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL110232D 1958-12-06 NL110232C (en:Method)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH6704658A CH370082A (de) 1958-12-06 1958-12-06 Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH6704958A CH371799A (de) 1958-12-06 1958-12-06 Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen
CH6820159A CH371800A (de) 1959-01-12 1959-01-12 Verfahren zur Herstellung von neuen N-heterocyclischen Verbindungen

Publications (1)

Publication Number Publication Date
NL110232C true NL110232C (en:Method)

Family

ID=27178525

Family Applications (1)

Application Number Title Priority Date Filing Date
NL110232D NL110232C (en:Method) 1958-12-06

Country Status (7)

Country Link
US (1) US3467650A (en:Method)
BE (1) BE585367A (en:Method)
CY (1) CY334A (en:Method)
ES (2) ES253960A1 (en:Method)
FR (1) FR278M (en:Method)
GB (1) GB934630A (en:Method)
NL (1) NL110232C (en:Method)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3886170A (en) * 1974-04-22 1975-05-27 Robins Co Inc A H 5-(3-)SUBSTITUTED-10,11-DIHYDRO-5H-dibenz{8 b,f{9 azepines
US4017621A (en) * 1974-12-09 1977-04-12 Sumitomo Chemical Company, Limited 2-Morpholinyl tricyclic dibenzazepine compounds
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
EP2343073A3 (en) 2003-12-11 2011-10-12 Sepracor Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
RU2008122978A (ru) 2005-11-09 2009-12-20 Комбинаторкс, Инкорпорейтед (Us) Способы, композиции и наборы для лечения медицинских состояний
EA019919B1 (ru) 2007-04-13 2014-07-30 Саузерн Рисерч Инститьют Способ подавления роста или метастазирования ангиогенез-зависимой опухоли
EP2222342B1 (en) * 2007-11-28 2014-03-26 Nektar Therapeutics Oligomer-tricyclic conjugates
WO2011091050A1 (en) 2010-01-19 2011-07-28 Nektar Therapeutics Oligomer-tricyclic conjugates
WO2012079017A1 (en) 2010-12-10 2012-06-14 Nektar Therapeutics Hydroxylated tricyclic compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2813857A (en) * 1957-11-19 N-aminoalkylated substituted iminodi-
AT200578B (de) * 1956-11-13 1958-11-10 Geigy Ag J R Verfahren zur Herstellung von neuen N-Aminoalkylderivaten von Azepinen

Also Published As

Publication number Publication date
FR278M (fr) 1961-03-13
CY334A (en) 1965-12-21
BE585367A (fr) 1960-06-07
US3467650A (en) 1969-09-16
ES253960A1 (es) 1960-05-16
ES253961A1 (es) 1960-05-16
GB934630A (en) 1963-08-21

Similar Documents

Publication Publication Date Title
AT214638B (en:Method)
AT221043B (en:Method)
AT217439B (en:Method)
AT215747B (en:Method)
AT213908B (en:Method)
AT213316B (en:Method)
AT213446B (en:Method)
AT216227B (en:Method)
AT215751B (en:Method)
AT219868B (en:Method)
AT214270B (en:Method)
AT214348B (en:Method)
AT213670B (en:Method)
AT215738B (en:Method)
AT213631B (en:Method)
AT213558B (en:Method)
AT213557B (en:Method)
AT216612B (en:Method)
AT216749B (en:Method)
AT216771B (en:Method)
AT216803B (en:Method)
AT216831B (en:Method)
AT213472B (en:Method)
AT213313B (en:Method)
AT219815B (en:Method)